BLS Pharmaceuticals Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 20, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Capitalization	193	89	10	38	8	18
Market Cap Growth	98.30%	767.35%	-73.09%	395.11%	-57.14%	180.00%
Enterprise Value	191	87	8	34	6	16
Last Close Price	0.84	0.41	0.05	0.20	0.12	0.28
PE Ratio	21.17	18.11	-	-	-	-
PS Ratio	4.03	3.03	1.06	7.18	16.57	8.13
PB Ratio	9.58	7.33	3.10	2.53	-21.05	9.27
P/TBV Ratio	9.74	7.15	2.84	10.66	-	9.92
P/FCF Ratio	681.80	21.09	-	-	-	337.34
P/OCF Ratio	95.41	14.14	-	-	-	337.34
EV/Sales Ratio	3.98	2.99	0.88	6.45	12.19	7.36
EV/EBITDA Ratio	17.96	16.19	-	-	-	-
EV/EBIT Ratio	19.27	17.16	-	-	-	-
EV/FCF Ratio	673.91	20.79	-	-	-	305.44
Debt / Equity Ratio	0.27	0.13	0.22	0.04	-1.09	-
Debt / EBITDA Ratio	0.50	0.27	-	-	-	-
Debt / FCF Ratio	18.94	0.36	-	-	-	-
Net Debt / Equity Ratio	-0.11	-0.51	-0.10	-0.22	-0.91	-0.83
Net Debt / EBITDA Ratio	-0.22	-1.13	0.29	1.92	-0.78	4.50
Net Debt / FCF Ratio	-7.89	-1.46	0.09	2.76	-0.58	-30.15
Asset Turnover	1.94	2.23	0.79	0.58	0.30	0.73
Inventory Turnover	3.67	6.30	3.78	6.98	1.48	2.20
Quick Ratio	1.32	1.59	0.78	1.81	0.39	2.69
Current Ratio	2.79	2.46	1.92	2.25	0.49	3.37
Return on Equity (ROE)	66.14%	63.64%	-141.75%	-26.18%	-62.97%	-21.82%
Return on Assets (ROA)	24.99%	24.26%	-5.80%	-12.53%	-18.13%	-7.78%
Return on Capital Employed (ROCE)	40.70%	38.70%	-29.90%	-12.10%	122.60%	-19.30%
Earnings Yield	4.64%	5.52%	-130.21%	-5.10%	-6.43%	-2.77%
FCF Yield	0.15%	4.74%	-36.53%	-3.13%	-7.38%	0.30%
Buyback Yield / Dilution	-11.95%	-11.36%	-43.61%	-83.52%	-14.42%	-